MARIA N MIYASHIRO
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SAN DIEGO, CA NPI 1447649504
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CA Gilead Sciences, Inc. All categories
General Payments — all program years on this page
$949.79
- Category: General Payments
- Program years: PY2021–2024
- Record count: 37
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $255.07 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $255.07 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $114.80 | 1 |
| Novo Nordisk AS | $52.83 | 3 |
| Lilly USA, LLC | $45.93 | 2 |
| PFIZER INC. | $25.42 | 1 |
| Phadia US Inc. | $16.09 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1067582854 | Phadia US Inc. | $16.09 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100233766 | Novo Nordisk Inc | $17.05 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100257958 | Novo Nordisk Inc | $17.71 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100624860 | Novo Nordisk Inc | $18.07 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132109161 | PFIZER INC. | $25.42 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133698167 | Gilead Sciences, Inc. | $114.80 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135774110 | Lilly USA, LLC | $26.51 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135805274 | Lilly USA, LLC | $19.42 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.